Anglikon, November 18, 2021 Vitruvia Medical, which specializes in circular systems for highly complex medical devices, particularly robot-assisted surgery, has acquired its first customers for the reprocessing of single-use medical devices. Effectively, the company has been contracted by four hospitals, which are now linked to the Circular Clinic Supply Center in Schönebeck near Magdeburg, albeit slightly later than originally scheduled. The volume of sales in this segment is expected to range at around three to four million euros in the next year, but current new customer business is not expected to have any significant effect on this year’s figures. In light of this, the Board of Directors has revised down its financial planning for 2021.

Group sales for the current full year is now projected at just under 2.9 million euros. Originally, the company had set sales revenues at almost five million euros. According to the revised corporate planning, earnings before interest, taxes, depreciation and amortization are projected at -1.3 million euros. Previously, the Board expected to operate at break even.

The current situation is merely a deferral of revenues. With a comparatively high number of intensive care beds in hospitals still reserved for the treatment of potential Covid-19 patients, any non-urgent surgeries continue to be postponed. This does not, however, affect the successful business model of Vitruvia Medical in the medium term.

About Vitruvia

Vitruvia is Europe’s foremost technology company in the healthcare sector of the circular economy, focusing on innovative circular systems for highly complex medical devices, particularly in robot-assisted surgery. Supplemented by trading, repair of medical devices as well as consulting, qualification, and other services, Vitruvia supports hospitals in the transformation of their ORs to higher value added, increased safety and maximum resource efficiency. Vitruvia is dedicated to providing innovative and sustainable solutions that deliver advances in medical technology, customer benefits and economic success.

For more information visit: www.vitruvia-med.com

Press contact:
Wolfgang Böhm
BÖHM CONSULT AG
T +49 30 44 33 61 – 33
w.boehm@boehm-consult.de